Biotech · Public company · Boston, MA, US
Pyxis Oncology, Inc.
Ticker PYXS · SEC CIK 0001782223
Track this companyFree. Adds Pyxis Oncology, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline4
- pembrolizumabPhase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- PYX-201Phase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- PYX-106Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PYX-201Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Apr 15, 2025ClinicalTrials.gov NCT06795412 · fetched Nov 12, 2026
- Study of PYX-106 in Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started May 23, 2023ClinicalTrials.gov NCT05718557 · fetched Nov 12, 2026
- A Study of PYX-201 in Advanced Solid TumorsPHASE1 · RECRUITING · started Mar 14, 2023ClinicalTrials.gov NCT05720117 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 1, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 8, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 15, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
- 8-K/A · 8-K/ASEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026